1. Home
  2. ZNB vs INDP Comparison

ZNB vs INDP Comparison

Compare ZNB & INDP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Zeta Network Group Class A Ordinary Shares

ZNB

Zeta Network Group Class A Ordinary Shares

HOLD

Current Price

$2.10

Market Cap

4.1M

ML Signal

HOLD

Logo Indaptus Therapeutics Inc.

INDP

Indaptus Therapeutics Inc.

N/A

Current Price

$1.78

Market Cap

4.5M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
ZNB
INDP
Founded
N/A
2000
Country
United States
United States
Employees
14
N/A
Industry
Engineering & Construction
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.1M
4.5M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
ZNB
INDP
Price
$2.10
$1.78
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
706.4K
18.6K
Earning Date
N/A
03-17-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.10
$0.27
52 Week High
$9.78
$13.24

Technical Indicators

Market Signals
Indicator
ZNB
INDP
Relative Strength Index (RSI) 49.47 43.99
Support Level $0.59 $1.64
Resistance Level $5.22 $1.99
Average True Range (ATR) 0.96 0.11
MACD -0.19 0.01
Stochastic Oscillator 19.83 35.14

Price Performance

Historical Comparison
ZNB
INDP

About ZNB Zeta Network Group Class A Ordinary Shares

Zeta Network Group is an entertainment technology company with a network that focuses on the application of technology and artificial intelligence in the entertainment industry. It provides online entertainment performances and online education through its wholly-owned subsidiaries Color Metaverse and CACM. The curriculum developed by the company includes music, sports, animation, painting and calligraphy, film and television, and life skills, covering various aspects of entertainment, sports, and culture.

About INDP Indaptus Therapeutics Inc.

Indaptus Therapeutics Inc is a pre-clinical biotechnology company engaged in developing a novel and patented systemically-administered anti-cancer and anti-viral immunotherapy. It has developed a proprietary platform that exploits bacteria's natural ability to activate both innate and adaptive cellular immune pathways. The company's clinical candidate Decoy20, has the ability to elicit single-agent activity and durable anti-tumor responses in the combination setting against colorectal, hepatocellular, pancreatic carcinoma, and non-Hodgkin's lymphoma models.

Share on Social Networks: